Does epithelial sodium channel hyperactivity contribute to cystic fibrosis lung disease?

Journal of Physiology

Volumn 591, Issue 18, 2013, Pages 4377-4387

  Hobbs, Carey A ^a   Da Tan, Chong ^a   Tarran, Robert ^a,b  

^a Cystic Fibrosis Pulmonary Research and Treatment Center   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); ANION CHANNEL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL SODIUM CHANNEL;

CFTR GENE; CYSTIC FIBROSIS; ELECTROPHYSIOLOGY; GENE; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION; INTESTINE EPITHELIUM; LUNG ALVEOLUS EPITHELIUM; MOUSE; MUCUS; NEUTROPHILIA; NONHUMAN; PANCREAS; PATHOGENESIS; PRIORITY JOURNAL; REHYDRATION; REVIEW; SODIUM ABSORPTION; SWEAT GLAND; VAS DEFERENS; WATER ABSORPTION;

ABSORPTION; ANIMALS; CYSTIC FIBROSIS; EPITHELIAL SODIUM CHANNELS; HUMANS; LUNG; SODIUM;

EID: 84884284486     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.240861     Document Type: Review

References (85)

1. Althaus M (2013). ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art. Curr Mol Pharmacol 6, 3-12.
2. Alton EW, Khagani A, Taylor RFH, Logan-Sinclair R, Yacoub M & Geddes DM (1991). Effect of heart-lung transplantation on airway potential difference in patients with and without cystic fibrosis. Eur Respir J 4, 5-9.
3. + channel ENaC. J Biol Chem 280, 31587-31594.
4. Bangel-Ruland N, Sobczak K, Christmann T, Kentrup D, Langhorst H, Kusche-Vihrog K & Weber WM (2010). Characterization of the epithelial sodium channel delta-subunit in human nasal epithelium. Am J Respir Cell Mol Biol 42, 498-505.
5. Berdiev BK, Cormet-Boyaka E, Tousson A, Qadri YJ, Oosterveld-Hut HM, Hong JS, Gonzales PA, Fuller CM, Sorscher EJ, Lukacs GL & Benos DJ (2007). Molecular proximity of cystic fibrosis transmembrane conductance regulator and epithelial sodium channel assessed by fluorescence resonance energy transfer. J Biol Chem 282, 36481-36488.
6. (+) channels: subunit-subunit interactions and inhibition by the cystic fibrosis transmembrane conductance regulator. Biophys J 78, 1881-1894.
7. Bingle L, Barnes FA, Cross SS, Rassl D, Wallace WA, Campos MA & Bingle CD (2007). Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis. Respir Res 8, 79.
8. Bingle L & Bingle CD (2011). Distribution of human PLUNC/BPI fold-containing (BPIF) proteins. Biochem Soc Trans 39, 1023-1027.
9. Blouquit-Laye S, Dannhoffer L, Braun C, Dinh-Xuan AT, Sage E & Chinet T (2012). Effect of nitric oxide on epithelial ion transports in noncystic fibrosis and cystic fibrosis human proximal and distal airways. Am J Physiol Lung Cell Mol Physiol 303, L617-L625.
10. Boucher RC (1994). Human airway ion transport (Part 1). Am J Respir Crit Care Med 150, 271-281.
11. + permeability in cystic fibrosis human primary cell cultures. J Physiol 405, 77-103.
12. + transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest 78, 1245-1252.
13. Bove PF, Grubb BR, Okada SF, Ribeiro CM, Rogers TD, Randell SH, O'Neal WK & Boucher RC (2010). Human alveolar type II cells secrete and absorb liquid in response to local nucleotide signalling. J Biol Chem 285, 34939-34949.
14. + transport in normal and CF human bronchial epithelial cells is inhibited by BAY 39-9437. Am J Physiol Lung Cell Mol Physiol 281, L16-L23.
15. Butterworth MB, Zhang L, Heidrich EM, Myerburg MM & Thibodeau PH (2012). Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa. J Biol Chem 287, 32556-32565.
16. + transport. Am J Physiol Lung Cell Mol Physiol 288, L813-L819.
17. Chambers LA, Rollins BM & Tarran R (2007). Liquid movement across the surface epithelium of large airways. Respir Physiol Neurobiol 159, 256-270.
18. Chen JH, Stoltz DA, Karp PH, Ernst SE, Pezzulo AA, Moninger TO, Rector MV, Reznikov LR, Launspach JL, Chaloner K, Zabner J & Welsh MJ (2010). Loss of anion transport without increased sodium absorption characterizes newborn porcine cystic fibrosis airway epithelia. Cell 143, 911-923.
19. Clarke LL, Grubb BR, Yankaskas JR, Cotton CU, McKenzie A & Boucher RC (1994). Relationship of a non-CFTR mediated chloride conductance to organ-level disease in cftr(-/-) mice. Proc Natl Acad Sci U S A 91, 479-483.
20. Collawn JF, Lazrak A, Bebok Z & Matalon S (2012). The CFTR and ENaC debate: how important is ENaC in CF lung disease Am J Physiol Lung Cell Mol Physiol 302, L1141-L1146.
21. Colledge WH, Abella BS, Southern KW, Ratcliff R, Jiang C, Cheng SH, MacVinish LJ, Anderson JR, Cuthbert AW & Evans MJ (1996). Generation and characterization of a deltaF508 cystic fibrosis mouse model. Nat Genet 10, 445-452.
22. Cotton CU, Stutts MJ, Knowles MR, Gatzy JT & Boucher RC (1987). Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis. J Clin Invest 79, 80-85.
23. Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R & Boucher RC (2006). Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 354, 241-250.
24. Egan EA, Olver RE & Strang LB (1975). Changes in non-electrolyte permeability of alveoli and the absorption of lung liquid at the start of breathing in the lamb. J Physiol 244, 161-179.
25. + channel and airway surface liquid volume by serine proteases. Pflugers Arch 460, 1-17.
26. Garcia-Caballero A, Rasmussen JE, Gaillard E, Watson MJ, Olsen JC, Donaldson SH, Stutts MJ & Tarran R (2009). SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc Natl Acad Sci U S A 106, 11412-11417.
27. + channel. J Biol Chem 285, 32227-32232.
28. Grubb BR (1995). Ion transport across the jejunum in normal and cystic fibrosis mice. Am J Physiol Gastrointest Liver Physiol 268, G505-G513.
29. Grubb BR & Boucher RC (1999). Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 79, S193-S214.
30. Grubb BR, O'Neal WK, Ostrowski LE, Kreda SM, Button B & Boucher RC (2012). Transgenic hCFTR expression fails to correct beta-ENaC mouse lung disease. Am J Physiol Lung Cell Mol Physiol 302, L238-L247.
31. Grunder S, Firsov D, Chang SS, Jaeger NF, Gautschi I, Schild L, Lifton RP & Rossier BC (1997). A mutation causing pseudohypoaldosteronism type 1 identifies a conserved glycine that is involved in the gating of the epithelial sodium channel. EMBO J 16, 899-907.
32. + channels carrying Liddle's syndrome mutations. J Biol Chem 274, 13894-13899.
33. Hummler E, Barker P, Gatzy J, Beermann F, Verdumo C, Schmidt A, Boucher R & Rossier BC (1996). Early death due to defective neonatal lung liquid clearance in alpha ENaC-deficient mice. Nat Genet 12, 325-328.
34. Ji HL, Su XF, Kedar S, Li J, Barbry P, Smith PR, Matalon S & Benos DJ (2006). Delta-subunit confers novel biophysical features to alpha beta gamma-human epithelial sodium channel (ENaC) via a physical interaction. J Biol Chem 281, 8233-8241.
35. Jiang C, Finkbeiner WE, Widdicombe JH, McCray PB Jr & Miller SS (1993). Altered fluid transport across airway epithelium in cystic fibrosis. Science 262, 424-427.
36. Johannesson B, Hirtz S, Schatterny J, Schultz C & Mall MA (2012). CFTR regulates early pathogenesis of chronic obstructive lung disease in betaENaC-overexpressing mice. PLoS ONE 7, e44059.
37. (+) channel regulation by cytoplasmic and extracellular factors. Exp Cell Res 318, 1011-1019.
38. Kerem E, Bistritzer T, Hanukoglu A, Hofmann T, Zhou Z, Bennett W, MacLaughlin E, Barker P, Nash M, Quittell L, Boucher R & Knowles MR (1999). Pulmonary epithelial sodium channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 341, 156-162.
39. Kesimer M, Ehre C, Burns KA, Davis CW, Sheehan JK & Pickles RJ (2013). Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways. Mucosal Immunol 6, 379-392.
40. Kesimer M, Kirkham S, Pickles RJ, Henderson AG, Alexis NE, DeMaria G, Knight D, Thornton DJ & Sheehan JK (2009). Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways Am J Physiol Lung Cell Mol Physiol 296, L92-L100.
41. Kimura T, Kawabe H, Jiang C, Zhang W, Xiang YY, Lu C, Salter MW, Brose N, Lu WY & Rotin D (2011). Deletion of the ubiquitin ligase Nedd4L in lung epithelia causes cystic fibrosis-like disease. Proc Natl Acad Sci U S A 108, 3216-3221.
42. Knowles M, Gatzy J & Boucher R (1981). Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 305, 1489-1495.
43. Knowles M, Gatzy J & Boucher R (1983a). Relative ion permeability of normal and cystic fibrosis nasal epithelium. J Clin Invest 71, 1410-1417.
44. Knowles MR, Church NL, Waltner WE, Yankaskas JR, Gilligan P, King M, Edwards LJ, Helms RW & Boucher RC (1991). Aerosolized amiloride as a treatment of cystic fibrosis lung disease: a pilot study. Adv Exp Med Biol 290, 119-132.
45. Knowles MR, Stutts MJ, Spock A, Fischer N, Gatzy JT & Boucher RC (1983b). Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 221, 1067-1070.
46. - concentration. EMBO Rep 2, 1047-1051.
47. Konstan MW, Hilliard KA, Norvell TM & Berger M (1994). Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinical mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 150, 448-454.
48. Konstas AA, Koch JP & Korbmacher C (2003). cAMP-dependent activation of CFTR inhibits the epithelial sodium channel (ENaC) without affecting its surface expression. Pflugers Arch 445, 513-521.
49. Li H, Sheppard DN & Hug MJ (2004). Transepithelial electrical measurements with the Ussing chamber. J Cyst Fibros 3 Suppl 2, 123-126.
50. + hyperabsorption in murine airways. Am J Physiol Lung Cell Mol Physiol 304, L469-L480.
51. + conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways. J Clin Invest 102, 15-21.
52. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10, 487-493.
53. + channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease. Exp Physiol 94, 171-174.
54. Mall MA, Button B, Johannesson B, Zhou Z, Livraghi A, Caldwell RA, Schubert SC, Schultz C, O'Neal WK, Pradervand S, Hummler E, Rossier BC, Grubb BR & Boucher RC (2010). Airway surface liquid volume regulation determines different airway phenotypes in liddle compared with betaENaC-overexpressing mice. J Biol Chem 285, 26945-26955.
55. Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW & Boucher RC (1998). Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95, 1005-1015.
56. McGillivary G & Bakaletz LO (2010). The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway. PLoS ONE 5, e13224.
57. Mutesa L, Azad AK, Verhaeghe C, Segers K, Vanbellinghen JF, Ngendahayo L, Rusingiza EK, Mutwa PR, Rulisa S, Koulischer L, Cassiman JJ, Cuppens H & Bours V (2009). Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants. Chest 135, 1233-1242.
58. Myerburg MM, Butterworth MB, McKenna EE, Peters KW, Frizzell RA, Kleyman TR & Pilewski JM (2006). Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in cystic fibrosis. J Biol Chem 281, 27942-27949.
59. Myerburg MM, Harvey PR, Heidrich EM, Pilewski JM & Butterworth MB (2010). Acute regulation of the epithelial sodium channel in airway epithelia by proteases and trafficking. Am J Respir Cell Mol Biol 43, 712-719.
60. + channels. Clin Exp Nephrol 16, 35-43.
61. Qadri YJ, Rooj AK & Fuller CM (2012). ENaCs and ASICs as therapeutic targets. Am J Physiol Cell Physiol 302, C943-C965.
62. + self inhibition. J Physiol 588, 1211-1225.
63. Rauh R, Soell D, Haerteis S, Diakov A, Nesterov V, Krueger B, Sticht H & Korbmacher C (2013). A mutation in the beta-subunit of ENaC identified in a patient with cystic fibrosis-like symptoms has a gain-of-function effect. Am J Physiol Lung Cell Mol Physiol 304, L43-L55.
64. - channel function. Nature 402, 301-304.
65. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ, Rogan MP, Pezzulo AA, Karp PH, Itani OA, Kabel AC, Wohlford-Lenane CL, Davis GJ, Hanfland RA, Smith TL, Samuel M, Wax D, Murphy CN, Rieke A, Whitworth K, Uc A, Starner TD, Brogden KA, Shilyansky J, McCray PB, Jr, Zabner J, Prather RS & Welsh MJ (2008). Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321, 1837-1841.
66. Schild L, Lu Y, Gautschi I, Schneeberger E, Lifton RP & Rossier BC (1996). Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J 15, 2381-2387.
67. + channel. Proc Natl Acad Sci U S A 96, 5310-5315.
68. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O & Koller BH (1992). An animal model for cystic fibrosis made by gene targeting. Science 257, 1083-1088.
69. Soundararajan R, Lu M & Pearce D (2012). Organization of the ENaC-regulatory machinery. Crit Rev Biochem Mol Biol 47, 349-359.
70. + channel mechanism revealed by the acid-sensing ion channel 1 structure. IUBMB Life 60, 620-628.
71. Stoltz DA, Rokhlina T, Ernst SE, Pezzulo AA, Ostedgaard LS, Karp PH, Samuel MS, Reznikov LR, Rector MV, Gansemer ND, Bouzek DC, Alaiwa MH, Hoegger MJ, Ludwig PS, Taft PJ, Wallen TJ, Wohlford-Lenane C, McMenimen JD, Chen JH, Bogan KL, Adam RJ, Hornick EE, Nelson GA, Hoffman EA, Chang EH, Zabner J, McCray PB, Jr, Prather RS, Meyerholz DK & Welsh MJ (2013). Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs. J Clin Invest 123, 2685-2693.
72. Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC & Boucher RC (1995). CFTR as a cAMP-dependent regulator of sodium channels. Science 269, 847-850.
73. Stutts MJ, Knowles MR, Gatzy JT & Boucher RC (1986). Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium. Pediatr Res 20, 1316-1320.
74. Suaud L, Yan W, Carattino MD, Robay A, Kleyman TR & Rubenstein RC (2007). Regulatory interactions of N1303K-CFTR and ENaC in Xenopus oocytes: evidence that chloride transport is not necessary for inhibition of ENaC. Am J Physiol Cell Physiol 292, C1553-C1561.
75. (+) transport in response to apical fluid volume expansion in human H441 airway epithelial cells. Pflugers Arch 462, 431-441.
76. Tan CD, Smolenski RT, Harhun MI, Patel HK, Ahmed SG, Wanisch K, Yáñez-Muñoz RJ & Baines DL (2012). Br J Pharmacol 167, 368-382.
77. Tarran R, Button B, Picher M, Paradiso AM, Ribeiro CM, Lazarowski ER, Zhang L, Collins PL, Pickles RJ, Fredberg JJ & Boucher RC (2005). Normal and cystic fibrosis airway surface liquid homeostasis: the effects of phasic shear stress and viral infections. J Biol Chem 280, 35751-35759.
78. Tarran R, Grubb BR, Gatzy JT, Davis CW & Boucher RC (2001a). The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol 118, 223-236.
79. Tarran R, Grubb BR, Parsons D, Picher M, Hirsh AJ, Davis CW & Boucher RC (2001b). The CF salt controversy: in vivo observations and therapeutic approaches. Mol Cell 8, 149-158.
80. Tarran R, Trout L, Donaldson SH & Boucher RC (2006). Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia. J Gen Physiol 127, 591-604.
81. Thibodeau PH & Butterworth MB (2013). Proteases, cystic fibrosis and the epithelial sodium channel (ENaC). Cell Tissue Res 351, 309-323.
82. Ussing HH & Zerhan K (1951). Active transport of sodium as the source of electric current in the short-circuited isolated frogskin. Acta Physiol Scand 23, 110-127.
83. Woollhead AM & Baines DL (2006). Forskolin-induced cell shrinkage and apical translocation of functional enhanced green fluorescent protein-human alphaENaC in H441 lung epithelial cell monolayers. J Biol Chem 281, 5158-5168.
84. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC & Doering G (2002). Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109, 317-325.
85. Zhou Z, Duerr J, Johannesson B, Schubert SC, Treis D, Harm M, Graeber SY, Dalpke A, Schultz C & Mall MA (2011). The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease. J Cyst Fibros 10 Suppl 2, S172-S182.